Arcadia Biosciences (RKDA) Peer Comparison
$0.49
$-0.02
(-3.69%)
As on 03-Sep-2026 11:31EDT
Market cap
$1 Mln
Revenue (TTM)
$5 Mln
P/E Ratio
--
P/B Ratio
2
Div. Yield
0 %
Edit
| Arcadia Biosciences (RKDA) | Scotts Miracle-Gro Company (SMG) | Ashland Global Holdings (ASH) | Hawkins (HWKN) | Chemours Co (CC) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
1 | 3,552 | 3,335 | 2,512 | 2,361 |
Revenue ($ Mln) |
5 | 3,373 | 1,843 | 1,106 | 5,797 |
Net Profit ($ Mln) |
-11.13 | 74.00 | 52.00 | 80.63 | -304.00 |
Net Margin (%) |
-234.53 | 2.19 | 2.82 | 7.29 | -5.24 |
RoE (%) |
-466.42 | -- | 2.77 | 15.11 | -- |
Price to Earnings |
-- | 23.56 | 46.38 | 30.47 | -- |
Price-To-Book |
1.95 | 21.95 | 1.77 | 4.48 | 12.54 |
Income Statement ($ Mln)
| Arcadia Biosciences (RKDA) | Scotts Miracle-Gro Company (SMG) | Ashland Global Holdings (ASH) | Hawkins (HWKN) | Chemours Co (CC) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
4.75 | 3,373.40 | 1,843.00 | 1,106.10 | 5,797.00 |
|
Cost of Revenue
|
3.11 | 2,284.80 | 1,302.00 | 859.40 | 4,908.00 |
|
Gross Profit
|
1.76 | 1,044.20 | 549.00 | 212.74 | 902.00 |
|
Operating Expenses
|
5.70 | 673.80 | 406.00 | 132.66 | 1,193.00 |
|
Operating Profit (EBIT)
|
-4.06 | 414.80 | 135.00 | 114.04 | -304.00 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-11.12 | 266.20 | 125.00 | 107.66 | -117.00 |
|
Provision for Tax
|
0.01 | 98.90 | 50.00 | 27.03 | 188.00 |
|
Profit after Tax (Net Income)
|
-11.13 | 74.00 | 52.00 | 80.63 | -304.00 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 | 1.00 |
|
Consolidated Profit
|
0.00 | -276.90 | 20.00 | 0.00 | -1.00 |
Liabilities ($ Mln)
| Arcadia Biosciences (RKDA) | Scotts Miracle-Gro Company (SMG) | Ashland Global Holdings (ASH) | Hawkins (HWKN) | Chemours Co (CC) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
0.63 | -208.70 | 1,870.00 | 548.20 | -49.00 |
|
Minority Interest
|
0.00 | 0.00 | 0.00 | 0.00 | 1.00 |
|
Non-Current Liabilities
|
3.61 | 2,265.30 | 2,284.00 | 348.43 | 5,337.00 |
|
Current Liabilities
|
1.65 | 1,110.80 | 424.00 | 109.61 | 1,861.00 |
|
Total Liabilities
|
6.55 | 2,742.00 | 4,611.00 | 769.87 | 7,382.00 |
Assets ($ Mln)
| Arcadia Biosciences (RKDA) | Scotts Miracle-Gro Company (SMG) | Ashland Global Holdings (ASH) | Hawkins (HWKN) | Chemours Co (CC) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.15 | 1,818.30 | 3,286.00 | 757.46 | 4,056.00 |
|
Current Assets
|
5.74 | 1,349.10 | 1,292.00 | 248.78 | 3,094.00 |
|
Total Assets
|
6.55 | 2,742.00 | 4,611.00 | 769.87 | 7,382.00 |
|
Total Debt*
|
0.00 | 2,113.30 | 1,476.00 | 260.67 | 4,120.00 |
|
Net Current Assets
|
0.00 | 238.30 | 868.00 | 139.17 | 1,233.00 |
Cashflow ($ Mln)
| Arcadia Biosciences (RKDA) | Scotts Miracle-Gro Company (SMG) | Ashland Global Holdings (ASH) | Hawkins (HWKN) | Chemours Co (CC) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-4.74 | 371.30 | 94.00 | 111.10 | 264.00 |
|
Cash Flow from Investing Activities
|
0.75 | -112.10 | -3.00 | -127.95 | -206.00 |
|
Cash from Financing Activities
|
0.01 | -294.00 | -179.00 | 14.81 | -126.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Arcadia Biosciences (RKDA) | Scotts Miracle-Gro Company (SMG) | Ashland Global Holdings (ASH) | Hawkins (HWKN) | Chemours Co (CC) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-44.48 | 7.00 | -21.63 | 14.83 | -7.88 |
|
ROE (%)
|
-466.42 | -38.82 | 2.77 | 15.11 | -90.40 |
|
ROA (%)
|
-104.72 | 1.81 | 1.04 | 7.28 | -3.31 |
|
EBIT Margin (%)
|
-102.34 | 10.44 | 10.26 | 10.91 | -6.97 |
|
Net Margin (%)
|
-234.53 | 2.19 | 2.82 | 7.29 | -5.24 |
|
Cash Profit Margin (%)
|
-0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Arcadia Biosciences (RKDA) | Scotts Miracle-Gro Company (SMG) | Ashland Global Holdings (ASH) | Hawkins (HWKN) | Chemours Co (CC) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-12.24 | -1.95 | -1.39 | 9.32 | -1.38 |
|
EBIT Growth (%)
|
8.70 | 49.66 | 124.14 | -1.20 | -2,785.71 |
|
Net Profit Growth (%)
|
-47.72 | 39.36 | 106.05 | -4.74 | 27.62 |
|
EPS Growth (%)
|
-47.39 | 49.30 | 106.06 | -4.79 | 28.18 |
|
Book Value Growth (%)
|
-86.05 | -21.09 | -1.01 | 12.90 | -120.52 |
Valuation Ratios
| Arcadia Biosciences (RKDA) | Scotts Miracle-Gro Company (SMG) | Ashland Global Holdings (ASH) | Hawkins (HWKN) | Chemours Co (CC) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-1.16 | 22.63 | -2.61 | 26.18 | -4.60 |
|
Price / Book Value
|
0.65 | -9.19 | 1.16 | 4.80 | 7.10 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
0.81 | 13.23 | -7.00 | 14.81 | 17.13 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Arcadia Biosciences (RKDA) | Scotts Miracle-Gro Company (SMG) | Ashland Global Holdings (ASH) | Hawkins (HWKN) | Chemours Co (CC) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | -8.80 | 0.73 | 0.45 | -78.33 |
|
Short term debt to equity ratio
|
0.00 | -1.33 | 0.01 | 0.01 | -1.86 |
|
Current Ratio
|
3.49 | 1.21 | 3.05 | 2.27 | 1.66 |
|
Quick Ratio
|
2.92 | 0.78 | 1.89 | 1.54 | 0.88 |
|
Interest Coverage
|
-- | 3.35 | 3.05 | 15.42 | 0.57 |
Operating Efficiency Ratios
| Arcadia Biosciences (RKDA) | Scotts Miracle-Gro Company (SMG) | Ashland Global Holdings (ASH) | Hawkins (HWKN) | Chemours Co (CC) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
11.78 | 21.14 | 13.89 | 13.72 | 15.65 |
|
Asset Turnover
|
0.45 | 0.83 | 0.37 | 1.00 | 0.63 |
|
Receivable days
|
60.15 | 19.46 | 48.56 | 46.69 | 45.56 |
|
Inventory Days
|
124.74 | 90.99 | 159.42 | 37.91 | 113.20 |
|
Payable days
|
127.09 | 37.31 | 57.72 | 28.19 | 76.27 |
|
Cash Conversion Cycle
|
57.79 | 73.15 | 150.26 | 56.41 | 82.49 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
